USPH
U.S. Physical Therapy, Inc.
Set alert
85.83 USD -0.74 -0.85%
85.19 Day range 87.62
59.00 52-week range 88.73
- YTD
- +9.91%
- 1 year
- -0.45%
- Open
- 87.26
- Prev close
- 86.57
- Mkt cap
- 1.28B
- Vol
- 146.43K
- Avg vol
- 184.54K
- EPS
- 0.18
- P/E
- 476.83
- Div yield
- 2.13%
More statistics
- Low
- 85.19
- High
- 87.62
- Forward P/E
- 25.69
- Beta
- 1.11
- Short ratio
- 6.28
- Inst. own
- 112.49%
- Dividend
- 1.84
- Ex-div date
- Aug 20, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 82.66
- 200-d avg
- 76.75
- 1y target
- 97.83
Key statistics
- Market cap
- 1.28B
- Enterprise value
- 1.97B
- Trailing P/E
- 474.94
- Forward P/E
- 25.69
- PEG ratio
- 2.84
- Price / sales
- 1.59
- Price / book
- 2.84
- EPS (TTM)
- 0.18
- Beta
- 1.11
- Dividend yield
- 2.13%
- Payout ratio
- 1011.11%
- Profit margin
- 4.01%
- Revenue (TTM)
- 804.27M
- Revenue growth
- 8.50%
- Free cash flow
- 41.29M
- Total cash
- 26.26M
- Total debt
- 385.79M
- Return on equity
- 6.51%
- Shares outstanding
- 14.92M
- Short % of float
- 9.58%
- 50-day average
- 82.66
- 200-day average
- 76.75
Analyst view
Consensus: buy
Buy
Price target (mean) 97.83 +14.0% upside
Now 85.83
- Target (low)
- 95.00
- Target (mean)
- 97.83
- Target (high)
- 101.00
Ratings (0m) 7 6 buy · 1 hold · 0 sell
- Strong buy4
- Buy2
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.725.
Financials — quick view
USPH Revenue — quarterly 214.06M
USPH Net income — quarterly 9.90M
USPH EPS — quarterly 0.25
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 0.756 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 0.814 | 0.75 | -0.06 | -7.86% |
| May 6, 2026 | Mar 31, 2026 | 0.55 | 0.46 | -0.09 | -16.36% |
| Feb 25, 2026 | Dec 31, 2025 | 0.67 | 0.67 | 0.00 | 0.00% |
| Nov 5, 2025 | Sep 30, 2025 | 0.67 | 0.66 | -0.01 | -1.49% |
| Aug 6, 2025 | Jun 30, 2025 | 0.71 | 0.81 | +0.10 | +14.08% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 11, 2026 | JP Morgan | main | Overweight | Overweight |
| Aug 10, 2026 | Barrington Research | main | Outperform | Outperform |
| Jun 24, 2026 | Citizens | reit | Market Outperform | Market Outperform |
| May 13, 2026 | Barrington Research | main | Outperform | Outperform |
| May 8, 2026 | Citizens | main | Market Outperform | Market Outperform |
| Feb 20, 2026 | Barrington Research | main | Outperform | Outperform |
About U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- usph.com
News
- Transcript: US Physical Therapy Q2 2026 Earnings Conference Call
- JP Morgan Maintains Overweight on US Physical Therapy, Raises Price Target to $95
- Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $98
- US Physical Therapy Q2 Adj. EPS $0.75 Misses $0.84 Estimate, Sales $214.059M Beat $211.307M Estimate
- U.S. Physical Therapy Acquires Majority Stake In Twelve-Clinic Physical Therapy Practice; Financial Terms Undisclosed
- Citizens Reiterates Market Outperform on US Physical Therapy, Maintains $98 Price Target
- Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $90
- Citizens Maintains Market Outperform on US Physical Therapy, Lowers Price Target to $98
- Earnings Scheduled For May 6, 2026
- US Physical Therapy Q1 Adj. EPS $0.46 Misses $0.55 Estimate, Sales $198.286M Miss $201.007M Estimate
Your note
Sign in to keep a note on USPH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BINSTEIN RICHARD S | General Counsel | Sale | Mar 5, 2026 | 24,867 |
| GILMARTIN KATHLEEN A | Director | Stock Award(Grant) | May 18, 2026 | 27,092 |
| HARRIS BERNARD A. JR | Director | Stock Award(Grant) | May 18, 2026 | 20,914 |
| HENDRICKSON CAREY P | Chief Financial Officer | Stock Award(Grant) | Feb 22, 2026 | 37,808 |
| MOTSENBOCKER ANNE | Director | Stock Award(Grant) | May 18, 2026 | 9,812 |
| READING CHRISTOPHER J | Chief Executive Officer | Stock Award(Grant) | Feb 22, 2026 | 139,088 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.17% | 2,264,202 | 193.57M | Jun 29, 2026 |
| Copeland Capital Management, LLC | 6.30% | 940,528 | 80.41M | Sep 29, 2026 |
| Bahl & Gaynor LLC | 5.77% | 861,574 | 73.66M | Jun 29, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 5.67% | 846,674 | 72.38M | Jun 29, 2026 |
| State Street Corporation | 4.74% | 707,186 | 60.46M | Jun 29, 2026 |
| Morgan Stanley | 4.68% | 698,690 | 59.73M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 888,029 | 75.92M | Sep 29, 2026 |
| ETF Series Solutions-Bahl & Gaynor Small/Mid Cap Income Growth ETF | 3.89% | 581,135 | 49.68M | Jun 29, 2026 |
| NEUBERGER BERMAN EQUITY FUNDS-Neuberger Genesis Fund | 3.78% | 563,592 | 48.18M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.25% | 484,591 | 41.43M | Jun 29, 2026 |
| American Century Mutual Funds, Inc.-Small Cap Growth Fund | 2.84% | 424,530 | 36.29M | Jul 30, 2026 |
| Virtus Equity Trust-Virtus KAR Small-Cap Growth Fund | 2.64% | 393,615 | 33.65M | Jun 29, 2026 |